Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on Dru…
Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared firs…
This chart shows the pharmaceutical companies with the most insert dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most insert dosed drugs…
The post Which pharmaceutical companies have the most insert…
Which pharmaceutical companies have the most insert dosed drugs? Read Post »
VIMPAT (lacosamide) Ucb inc Patent: RE38551 Expiration: Mar 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expira…
Drug Patent Expirations for the Week of March 13, 2022 Read Post »
This chart shows the pharmaceutical companies with the most aerosol dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most aerosol dosed drugs…
The post Which pharmaceutical companies have the most aero…
Which pharmaceutical companies have the most aerosol dosed drugs? Read Post »
VIMPAT (lacosamide) Ucb inc Patent: RE38551 Expiration: Mar 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expira…
Drug Patent Expirations for the Week of March 13, 2022 Read Post »
This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…
The post Pharmaceutical companies with the most ‘P…
Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs Read Post »
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWat…
This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Norway? …
Which pharmaceutical drugs have the most drug patents in Norway? Read Post »
Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug GILOTRIF appeared f…
New patent for Boehringer Ingelheim drug GILOTRIF Read Post »
Get new actionable insights and updates from BiotechBlog
